Skip to main content

BioTech

FALCON siRNA Therapies to Help Patients With Ocular, Neuromuscular, and CNS Diseases

Published

Aug 30, 2021

DTx Pharma Co-Founder & CEO Arthur Suckow discusses FALCON siRNA therapies to help patients with ocular, neuromuscular, and CNS diseases.

No transcript available

More in this Series

See all

A Drug Being Developed to Treat Anxiety and Cognitive Decline in the Elderly

Aug 9, 2023
Making Drugs Better by Turning Injectable Drugs Into Pill Form

Aug 9, 2023
Powering Healthcare Ventures: Alpha Healthcare Acquisition Corp III

Jul 6, 2023

My Quotes
My European Quotes
Watchlist
Portfolio

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Stocks, Funds, ETFs and more asset classes.

/

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Shares, Indexes, ETP and more asset classes.

/

Edit Watchlist

Your Watchlist is empty.

Create your Watchlist to save your favorite quotes on Nasdaq.com. Log in or create a free account to get started.

/

Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. Go to Smart Portfolio